Industry Strength Score
22/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
APPLIED DNA SCIENCES INC (APDN) Stock Price & Overview
NASDAQ:APDN • US03815U6073
Current stock price
5.62 USD
+1.35 (+31.62%)
At close:
6.18 USD
+0.56 (+9.96%)
After Hours:
The current stock price of APDN is 5.62 USD. Today APDN is up by 31.62%. In the past month the price increased by 142.24%. In the past year, price decreased by -97.62%.
APDN Key Statistics
52-Week Range2.13 - 319.95
Current APDN stock price positioned within its 52-week range.
1-Month Range2.28 - 7.15
Current APDN stock price positioned within its 1-month range.
- Market Cap
- 7.25M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -924.25
- Dividend Yield
- N/A
APDN Stock Performance
Today
+31.62%
1 Week
+7.46%
1 Month
+142.24%
3 Months
+9.13%
Longer-term
6 Months -67.42%
1 Year -97.62%
2 Years -99.95%
3 Years -99.98%
5 Years -100.00%
10 Years -100.00%
APDN Stock Chart
APDN Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to APDN. When comparing the yearly performance of all stocks, APDN is a bad performer in the overall market: 95.84% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
APDN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to APDN. While APDN seems to be doing ok healthwise, there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
APDN Earnings
On August 14, 2025 APDN reported an EPS of -34 and a revenue of 304.39K. The company beat EPS expectations (11.11% surprise) and missed revenue expectations (-76.62% surprise).
Next Earnings DateDec 15, 2025
Last Earnings DateAug 14, 2025
PeriodQ3 / 2025
EPS Reported-$34.00
Revenue Reported304.39K
EPS Surprise 11.11%
Revenue Surprise -76.62%
APDN Forecast & Estimates
For the next year, analysts expect an EPS growth of 92.97% and a revenue growth 50.26% for APDN
Analysts
Analysts43.33
Price TargetN/A
EPS Next Y92.97%
Revenue Next Year50.26%
APDN Financial Highlights
Over the last trailing twelve months APDN reported a non-GAAP Earnings per Share(EPS) of -924.25. The EPS increased by 89.59% compared to the year before.
Income Statements
Revenue(TTM)3.30M
Net Income(TTM)-67.51M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -679.56% | ||
| ROE | -929.59% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%-109.65%
Sales Q2Q%-61.81%
EPS 1Y (TTM)89.59%
Revenue 1Y (TTM)-2.96%
APDN Ownership
Ownership
Inst OwnersN/A
Shares1.29M
Float1.28M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
APDN Industry Overview
APDN operates in the Life Sciences Tools & Services sub-industry within the Health Care sector. This group contains 50 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
51/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
39%
Outperformed 39% of sub-industries
3 Month Rank
8%
Outperformed 8% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 50
- New Highs
- 0%
- New Lows
- 8%
- Average ROE
- 15.1%
- Average Profit Margin
- 15.6%
- Average Operating Margin
- 18.8%
- Average P/E
- 33.7
- Average Fwd P/E
- 28.9
- Average Debt/Equity
- 0.8
APDN Competitors/Peers
The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 17.32 | 174.368B | ||
| DHR | DANAHER CORP | 19.03 | 123.954B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.35 | 44.523B | ||
| A | AGILENT TECHNOLOGIES INC | 17.04 | 32.363B | ||
| WAT | WATERS CORP | 21.12 | 30.15B | ||
| IQV | IQVIA HOLDINGS INC | 12.3 | 26.485B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.98 | 25.658B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 33.45 | 21.673B | ||
| ILMN | ILLUMINA INC | 22.75 | 20.626B | ||
| MEDP | MEDPACE HOLDINGS INC | 21.57 | 11.925B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.867B | ||
| RVTY | REVVITY INC | 15.75 | 9.691B | ||
| TECH | BIO-TECHNE CORP | 24.77 | 8.608B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About APDN
Company Profile
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The firm is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The firm operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Company Info
IPO: 2001-08-24
APPLIED DNA SCIENCES INC
50 Health Sciences Drive
Stony Brook NEW YORK 11790 US
CEO: James A. Hayward
Employees: 47
Phone: 16312408800
APPLIED DNA SCIENCES INC / APDN FAQ
Can you describe the business of APPLIED DNA SCIENCES INC?
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The firm is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The firm operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
What is the stock price of APPLIED DNA SCIENCES INC today?
The current stock price of APDN is 5.62 USD. The price increased by 31.62% in the last trading session.
Does APDN stock pay dividends?
APDN does not pay a dividend.
How is the ChartMill rating for APPLIED DNA SCIENCES INC?
APDN has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the employee count for APDN stock?
APPLIED DNA SCIENCES INC (APDN) currently has 47 employees.
Can you provide the market cap for APPLIED DNA SCIENCES INC?
APPLIED DNA SCIENCES INC (APDN) has a market capitalization of 7.25M USD. This makes APDN a Nano Cap stock.